Objective To investigate the effect of Guben Pingxiao Decoction combined with western medicine on lung function and serum T lymphocyte subsets in patients with lung-kidney deficiency syndrome during asthma remission. Methods From February 2017 to March 2019

80 patients with lung-kidney deficiency syndrome in asthma remission who were treated in a hospital in Shenyang City were selected as the research subjects. The patients were divided into observation group and control group by random number table method

with 40 cases in each group. Patients in the control group were given budesonide inhalation inhalation treatment. Patients in the observation group were given Guben Pingxiao Decoction on the basis of treatment in the control group. Both groups of patients continued treatment for 12 weeks. The treatment effects and adverse reactions of the two groups were compared; the clinical symptom score

lung function changes

and serum T lymphocyte subgroup levels were compared between the two groups. Results A total of 30 patients in the control group were effective in treatment（6 cases were clinically controlled

9 cases were markedly effective

15 cases were effective）

and the total effective rate was 75.00%. The observation group had a total effective treatment of 37 patients（7 clinically controlled

16 significantly effective

and 14 effective）

and the total effective rate was 92.50%. The treatment efficiency of the observation group was higher than that of the control group

and the difference was statistically significant（P

<

0.05）. There was no significant difference in the clinical symptoms（wheezing

chest tightness

chills

coldness

fatigue

waist and knee weakness

tinnitus and dizziness） of the two groups of patients before treatment（P

>

0.05）. After treatment

the scores of clinical symptoms（wheezing

chest tightness

chills

fatigue

fatigue of the waist and knees

and tinnitus and dizziness） in the two groups were lower than before treatment

and the observation group was significantly lower than the control group. P

<

0.05). There was no significant difference in FEV1/FVC

FEV1% and PEF% between the two groups before treatment（P

>

0.05）. After treatment

the FEV1/FVC

FEV1%

and PEF% of the two groups were higher than those of the control group

and the observation group was higher than that of the control group

and the differences were statistically significant（P

<

0.05）. There was no significant difference in the levels of CD4

+

CD8

+

and CD4

+

/CD8

+

between the two groups before treatment（P

>

0.05）. After treatment

the levels of CD4

+

and CD4

+

/CD8

+

in the two groups were higherthan before treatment

and the observation group was higher than in the control group

and the differences were statistically significant（P

<

0.05）. After treatment

the CD8

+

levels in the two groups were lower than the treatment The patients in the observation group were lower than those in the control group

and the difference was statistically significant（P

<

0.05）. Two patients in the control group had adverse reactions

and the incidence of adverse reactions was 5.00%. Three patients had adverse reactions in the observation group

and the incidence of adverse reactions was 7.50%. The incidence of adverse reactions was higher in the observation group than in the control group

but the difference was not statistically significant（P

>

0.05）. Conclusion Guber Pingxiao Decoction combined with western medicine can effectively improve the clinical symptoms of patients with lung-kidney deficiency syndrome during remission of asthma

improve the lung function and immune function of the body

and it is effective and safe. It is worthy of clinical popularization.